Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 1 - 10 out of 209

AMIA Supports Sustained NIH Funding

March 11, 2025

The letter, endorsed by over 600 organizations including AMIA, urges Congress to allocate at least a $1.77 billion increase for the National Institutes of Health (NIH) in the Fiscal Year 2025 appropriations bill. 

It emphasizes the necessity of preserving existing protections against cuts to reimbursement for NIH grantee Facilities and […]

HHS HIPAA Security Rule to Strengthen the Cybersecurity of ePHI Proposed Rule

March 7, 2025

Thank you for the opportunity to address changes in the NPRM, HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information. These proposals represent the first significant revision of the HIPAA Security Rule in over a decade, addressing the increased risks posed by advancements in technology and the […]

Friends of AHRQ Letter Calling Congress to Fully Fund AHRQ

March 3, 2025


AMIA joined the Friends of AHRQ to send a sign-on letter to Congress with over 190 signatories representing doctors, patients, researchers, health systems, and more, calling on them to fully fund AHRQ for FY26.

Funding AHRQ is critical for supporting health services research, implementing high value and accessible care, and […]

Protecting Telehealth Access Letter to AG Bondi

February 20, 2025

Led by Alliance for Connected Care, AMIA signed onto a letter to congratulate Pam Bondi on her appointment as U.S. Attorney General and urge her to rescind a proposed telehealth rule that restricts virtual prescribing of controlled substances. With temporary telehealth flexibilities ending in December 2025, millions risk losing critical […]

USCDI+ Cancer - Clinical Trials Matching Draft Dataset

December 20, 2024

AMIA submitted comments to the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP/ONC) USCDI+ Cancer – Clinical Trials Matching draft dataset use case. 

Letter to Congressional Leadership Extending Telehealth Flexibilities Beyond Year-End

December 11, 2024

On behalf of the signatories below, we thank you for your ongoing efforts to advance access to health care through telehealth. We write today to re-emphasize the importance of creating predictability by extending current telehealth flexibilities in an end-of-year package for a full year or more.
Both patients and practitioners […]

AMIA Comments on CHAI Assurance Standards Guide and Assurance Reporting Checklists

September 25, 2024

AMIA commented on (Coalition for Health AI) CHAI’s Assurance Standards Guide and Reporting Checklists and supports CHAI products to be the best they can be for consumer use. AMIA applauded the vast effort CHAI undertook to create this comprehensive document and the associated Checklist. Click the link below to read […]